An in Vivo shRNA-Drug Screen to Identify Novel Targeted Therapy Combinations for KRAS Mutant Cancers

doi 10.21236/ada620992
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy